Onyx Pharmaceuticals to Present at BIO Investor Forum Conference
October 12 2006 - 4:00PM
PR Newswire (US)
EMERYVILLE, Calif., Oct. 12 /PRNewswire-FirstCall/ -- Onyx
Pharmaceuticals, Inc. (NASDAQ:ONXX) today announced that it will
present at the BIO Investor Forum conference on Wednesday, October
18, at 11:00 a.m. Pacific Time. Interested parties may access a
live webcast of the presentation at:
http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=ONXX&item_id=1399841
It is recommended that listeners log on 15 minutes early in order
to register and download any necessary software. For those unable
to participate during the live webcast, a recorded replay of the
presentation will be available within 24 hours of the completion of
the presentation through November 18, 2006. Onyx Pharmaceuticals,
Inc. is a biopharmaceutical company developing innovative therapies
that target the molecular mechanisms that cause cancer. The company
is developing Nexavar(R), a small molecule drug, with Bayer
Pharmaceuticals Corporation. Nexavar has been approved for the
treatment of advanced kidney cancer. For more information about
Onyx's pipeline and activities, visit the company's web site at:
http://www.onyx-pharm.com/. NOTE: Nexavar(R) (sorafenib) tablets is
a registered trademark of Bayer Pharmaceuticals Corporation.
DATASOURCE: Onyx Pharmaceuticals, Inc. CONTACT: Alexandra Santos of
Onyx Pharmaceuticals, Inc., +1-510-597-6504 Web site:
http://www.onyx-pharm.com/
Copyright
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Onyx Pharmaceuticals, Inc. (MM) (NASDAQ:ONXX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Onyx Pharmaceuticals, Inc. (MM) (NASDAQ): 0 recent articles
More Onyx Pharmaceuticals (MM) News Articles